CJC-1295 No DAC 5mg + Ipamorelin 5mg

Description

CJC-1295 No DAC 5mg + Ipamorelin 5mg from Nexum Peptides is a dual-pathway research peptide blend supplied exclusively for laboratory and scientific research. This combination pairs a GHRH analogue (CJC-1295 No DAC) with a selective ghrelin receptor agonist (Ipamorelin), studied for their synergistic influence on growth hormone signalling pathways in controlled research settings.

• Purity: ≥99% (HPLC tested)
• Form: Lyophilised powder
• Contents: CJC-1295 No DAC (5mg) + Ipamorelin (5mg)
• Reconstitution (research only): Add 2.5 ml bacteriostatic water → 2 mg/ml per peptide. Swirl gently; do not shake.
• Storage: 2–8 °C; –20 °C long-term. After reconstitution store at 2–8 °C and use within 28 days. Avoid repeated freeze–thaw cycles.

Research Applications:

• Growth hormone release signalling via dual GHRH and GHS-R pathways
• Cellular repair and tissue regeneration models
• Metabolic and body composition studies
• Recovery and anabolic response investigations

Disclaimer:
For research use only. Not intended for human or veterinary use. To be handled only by qualified research professionals. Certificate of Analysis (COA) included with every order.